US2010292231A1
|
|
Indazole Compounds for Treating Inflammatory Disorders, Demyelinating Disorders and Cancers
|
US2008108641A1
|
|
Compounds for treating inflammatory disorders, demyelinating disdorders and cancers
|
US2010016300A1
|
|
Imidazoacridine Compounds for Treating FLT3-Mediated Disorders
|
WO2008016700A2
|
|
N-oxide compounds for therapeutics uses
|
WO2008016661A2
|
|
Morpholino compounds for treating inflammatory and demyelinating diseases and cancers
|
WO2008016660A2
|
|
Imidazoacridine compounds for treating leukemias
|
WO2007092436A2
|
|
Compounds for treating inflammatory disorders, demyelinating disorders and cancers
|
US2006189546A1
|
|
Compounds for treating autoimmune and demyelinating diseases
|
WO0000636A2
|
|
In vivo determination of metabolic function for use in therapy management
|